Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.
Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS.
Marschner IC, et al. Among authors: degruttola v.
J Infect Dis. 1998 Jan;177(1):40-7. doi: 10.1086/513823.
J Infect Dis. 1998.
PMID: 9419168
Clinical Trial.